Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

醒脑静注射液 - NMPA Drug Approval Details

Approvals/NMPA/Unknown Drug

Approved

中药

Unknown Drug

大理药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 31, 2020
Approval ID: 7LeaeA8CQIj
Company: 大理药业股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeA8CQIj
Approval Number: 国药准字Z53021639
Generic Name: 醒脑静注射液
Drug Type: 中药
Dosage Form: 注射剂
Strength: 10ml
Reg Date: 2020-08-31
Company Name: 大理药业股份有限公司
Production Company Name: 大理药业股份有限公司
Production Company Address: 云南省大理市下关环城西路118号
Company Detail Path: /organization/dali-pharmaceutical-co-ltd
Production Company Detail Path: /organization/dali-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 31, 2020

Approval ID

7LeaeA8CQIj

Type

中药

Back to NMPA Approvals